Authors\u2019 response to \u201cEvaluation of Treatments for HIV-Associated Kaposi Sarcoma in Africa\u201d

Matthew E. Coldiron,Laurence Toutous Trellu,Ana Gabriela Gutierrez Zamudio,Lucas Molfino,Iza Ciglenecki,Rolanda Manuel

doi:10.1186/s13027-021-00372-5

Matthew E. Coldiron, Laurence Toutous Trellu

Open Access

https://doi.org/10.1186/s13027-021-00372-5

Copy DOI

Abstract

Authors\u2019 response to \u201cEvaluation of Treatments for HIV-Associated Kaposi Sarcoma in Africa\u201d

Highlights

We thank Drs Krown and Borok for the interest they have shown in our work and the opportunity they give us to draw attention to the extremely poor access to cancer treatment in resource-limited settings
We agree with several of their concerns about the limitations of our single-site observational study, many of which we presented in the discussion of our manuscript
Our loss to follow-up (13 %) was higher than in the clinical trial co-chaired by Drs Krown and Borok, but our study was not a clinical trial, and loss to follow up over the study period was much lower than in a historical cohort at the same center (36 %) [2, 3]

Summary

Introduction

We thank Drs Krown and Borok for the interest they have shown in our work and the opportunity they give us to draw attention to the extremely poor access to cancer treatment in resource-limited settings. We agree with several of their concerns about the limitations of our single-site observational study, many of which we presented in the discussion of our manuscript. We used standard outcome measures used in multiple previous studies and believe that this was prudent given * Correspondence: matthew.coldiron@epicentre.msf.org 1Epicentre, 14-34 Avenue Jean Jaurès, 75019 Paris, France Full list of author information is available at the end of the article the single-site, observational nature of our study.

Results

Conclusion